Eptinezumab
ATC N02CD05 · 10 markets · 14 records
AU 3 records · 3 strengths
- 100 mg/1 mLinjectionVyepti
- 100 mg/mLinjectionVYEPTI eptinezumab 100 mg/mL concentrated injection single use vial
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 2 records · 2 strengths
ES 2 records · 1 strengths
- 100 mginjectionVyepti
US 1 records · 1 strengths
- 100 mginjectionVyepti
GB 1 records · 1 strengths
- 100 mg/1 mLinjectionVyepti 100mg/1ml concentrate for solution for infusion vials
SG 1 records · 1 strengths
- 100 mg/mLinjectionVYEPTI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/ML
MX 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 1 records · 1 strengths
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
FR 1 records · 1 strengths
- 100 mg/1 mLinjectionVYEPTI 100 mg, solution à diluer pour perfusion
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|
| 100 mg/1 mL injection | Vyepti 100mg/1ml concentrate for solution for infusion vials | Vyepti | VYEPTI 100 mg, solution à diluer pour perfusion | |||||||
| 100 mg injection | Vyepti | Vyepti | ||||||||
| 100 mg/mL injection | VYEPTI eptinezumab 100 mg/mL concentrated injection single use vial | VYEPTI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/ML | ||||||||
| 100 mg liquid | Vyepti | |||||||||
| 100 mg/1 mL liquid | Vyepti | |||||||||
unknown | Vyepti | VYEPTI CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/1ML | Vyepti | |||||||
liquid | Vyepti |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in MX and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en MX que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 MX 有记录(未在本表显示)。 另有 1 個規格/劑型僅在 MX 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.